Patent details

EP1274457 Title: METHOD AND COMPOSITIONS FOR THE TREATMENT OF ALLERGIC CONDITIONS USING PGD2 RECEPTOR ANTAGONISTS

Basic Information

Publication number:
EP1274457
PCT Application Number:
PCT/CA/2001/000491
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP019234335
PCT Publication Number:
WO/2001/078697
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
METHOD AND COMPOSITIONS FOR THE TREATMENT OF ALLERGIC CONDITIONS USING PGD2 RECEPTOR ANTAGONISTS
French Title of Invention:
PROCEDE ET COMPOSITIONS DESTINES AU TRAITEMENT D'ETATS ALLERGIQUES FAISANT APPEL A DES ANTAGONISTES DU RECEPTEUR PGD2
German Title of Invention:
VERFAHREN UND ZUSAMMENSETZUNGEN ZUR BEHANDLUNG VON ALLERGISCHEN ZUSTÄNDEN MIT PGD2 REZEPTOR ANTAGONISTEN
SPC Number:

Dates

Filing date:
09/04/2001
Grant date:
30/11/2005
EP Publication Date:
30/11/2005
PCT Publication Date:
25/10/2001
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
15/01/2003
EP B1 Publication Date:
30/11/2005
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
09/04/2006
Expiration date:
09/04/2021
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
09/04/2001
 
 

Name:
Merck Frosst Canada & Co.
Address:
16711 Trans-Canada Highway, Kirkland, Quebec H9H 3L1, Canada (CA)

Inventor

Name:
JONES Thomas, R.
Address:
Canada (CA)

Priority

Priority Number:
196641 P
Priority Date:
12/04/2000
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 45/06;
Filing date Document type Number of pages